The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GO39775: A multicenter phase I trial evaluating the safety, pharmacokinetics, and activity of BFCR4350A, a FcRH5/CD3 T-cell dependent bispecific antibody, in patients with relapsed or refractory multiple myeloma.
 
Adam D. Cohen
Consulting or Advisory Role - Celgene; GlaxoSmithKline; Janssen; Oncopeptides; Seagen; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst); Poseida Therapeutics (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Novartis
Expert Testimony - Janssen
 
Suzanne Trudel
Honoraria - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene
Research Funding - Amgen; Celgene; Genentech; GlaxoSmithKline; Janssen
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Peter A. Forsberg
Consulting or Advisory Role - Pharmacyclics; Sanofi
Speakers' Bureau - Celgene
Research Funding - Abbvie; Amgen; Genentech; Sanofi
 
Rafael Fonseca
Stock and Other Ownership Interests - Adaptive Biotechnologies
Honoraria - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Patents, Royalties, Other Intellectual Property - Dr Fonseca has received a patent for the prognostication of MM based on genetic categorization of the disease.
Travel, Accommodations, Expenses - Abbvie; Aduro Biotech; Amgen; Bayer; Bristol-Myers Squibb; Celgene; Janssen; Juno Therapeutics; Kite, a Gilead company; Merck Sharp & Dohme; OncoTracker; Sanofi; Takeda
Other Relationship - Adaptive Biotechnologies
 
Amrita Y. Krishnan
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Adaptive Biotechnologies; Celgene; GlaxoSmithKline; Janssen Oncology; Sutter Medical Group
Speakers' Bureau - Amgen; Celgene; Takeda
Research Funding - Janssen Oncology (Inst)
 
Andrew Spencer
Honoraria - Abbvie; Amgen; Celgene; Haemalogix; Janssen; Sanofi; Secura Bio; SERVIER; Specialised Therapeutics; Takeda
Consulting or Advisory Role - Abbvie; Celgene; Haemalogix; Janssen; Sanofi; Secura Bio; SERVIER; Specialised Therapeutics
Speakers' Bureau - Celgene; Janssen
Research Funding - Amgen; Celgene; Haemalogix; Janssen; SERVIER; Takeda
 
Jesus G. Berdeja
Consulting or Advisory Role - Amgen (Inst); BioClinica (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); prothena (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CURIS (Inst); Genentech/Roche (Inst); Glenmark (Inst); Janssen (Inst); Kesios Therapuetics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst); Vivolux (Inst)
 
Sarah M. Hamirani
Stock and Other Ownership Interests - Genentech; Healthpeak
 
Mengsong Li
Employment - Genentech; Roche
Stock and Other Ownership Interests - Merck; Roche
 
James Cooper
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Travel, Accommodations, Expenses - Genentech
 
Simon J. Harrison
Honoraria - Abbvie (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); Novartis (Inst); Sanofi (Inst)
Consulting or Advisory Role - Abbvie (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Janssen-Cilag (Inst); Novartis (Inst); Sanofi (Inst)
Speakers' Bureau - Abbvie (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Novartis (Inst)
Research Funding - Juno Therapeutics (Inst)
Expert Testimony - Mallinckrodt (Inst)
Travel, Accommodations, Expenses - Abbvie (Inst); Celgene (Inst); Novartis (Inst)